Olav B. Bergheim is the Founder and Managing Director of Fjord Ventures. See sector focus and contact routes.
Olav B. Bergheim is the Founder and Managing Director of Fjord Ventures, a life sciences venture capital firm he established in 2005 in Laguna Hills, California, after previously serving as a general partner at Domain Associates. The firm specializes exclusively in the life sciences sector, funding and developing emerging companies within this field rather than pursuing broader technology or consumer investments. Fjord Ventures operates as a life sciences accelerator, with its portfolio including Adagio Medical, Allegro Medical, Anaxiom Corporation, Kato Pharmaceuticals, Metronom Health, Prelude Corporation, Sonendo, Volante Diagnostics, and YAP Therapeutics. While the firm has only one tracked investment in public databases—a $43.0 million Series E round in Adagio Medical in November 2020—its broader portfolio suggests active involvement across multiple life sciences companies. Bergheim also serves as Co-Founder and Executive Chairman of YAP Therapeutics, indicating a hands-on leadership role in at least one portfolio company. There is no publicly available information detailing his typical check size, lead/follow behavior, specific investment stages, geograph
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Laguna Hills.
Investors like Olav B. Bergheim · Full investor directory · Investor access · Company funding database